Genetic alterations are frequent in APC but rare in the TGF-β type II receptor gene in cancer in adenomas of the colon

被引:7
作者
Akiyama, Y
Yagi, OK
Ishikawa, T
Nagasaki, H
Saitoh, K
Yuasa, Y [1 ]
机构
[1] Tokyo Med & Dent Univ, Sch Med, Dept Hyg & Oncol, Bunkyo Ku, Tokyo 113, Japan
[2] Tokyo Med & Dent Univ, Sch Med, Dept Surg 1, Bunkyo Ku, Tokyo 113, Japan
[3] Int Med Ctr Japan, Dept Pathol, Shinjuku Ku, Tokyo 162, Japan
关键词
cancer in adenoma; APC; TGF-beta type II receptor; p53; beta-catenin;
D O I
10.1016/S0304-3835(97)00490-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Cancer in adenomas are thought to be an excellent model of colorectal carcinogenesis based on the adenoma-carcinoma sequence. We searched for alterations in the APC mutation cluster region, the whole coding regions of TGF-beta type II receptor (RII) and beta-catenin exon 3 in 16 cases of cancer in adenomas of the colon. Overexpression of the p53 protein was also analyzed. Nine of the 16 cases showed APC mutations in both the adenoma and cancer regions. Loss of heterozygosity in APC was found in one cancer in adenoma that had no mutation. p53 overexpression was detected in one adenoma and 10 cancerous regions, most of which also exhibited APC alterations. Two cases showed a missense mutation at codon 191 or loss of heterozygosity in TGF-beta RII in both the adenoma and cancer. Our data support the hypothesis that alterations of APC and p53 are responsible for most of the adenoma-carcinoma pathway, rather than TGF-P RII alterations. (C) 1998 Elsevier Science Ireland Ltd.
引用
收藏
页码:89 / 96
页数:8
相关论文
共 32 条
[1]
AALTONEN LA, 1994, CANCER RES, V54, P1645
[2]
Akiyama Y, 1996, CANCER-AM CANCER SOC, V78, P2478, DOI 10.1002/(SICI)1097-0142(19961215)78:12<2478::AID-CNCR5>3.0.CO
[3]
2-G
[4]
Transforming growth factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer [J].
Akiyama, Y ;
Iwanaga, R ;
Saitoh, K ;
Shiba, K ;
Ushio, K ;
Ikeda, E ;
Iwama, T ;
Nomizu, T ;
Yuasa, Y .
GASTROENTEROLOGY, 1997, 112 (01) :33-39
[5]
BAKER SJ, 1990, CANCER RES, V50, P7717
[6]
MICROALLELOTYPING DEFINES THE SEQUENCE AND TEMPO OF ALLELIC LOSSES AT TUMOR-SUPPRESSOR GENE LOCI DURING COLORECTAL-CANCER PROGRESSION [J].
BOLAND, CR ;
SATO, J ;
APPELMAN, HD ;
BRESALIER, RS ;
FEINBERG, AP .
NATURE MEDICINE, 1995, 1 (09) :902-909
[7]
beta-Catenin mutations in cell lines established from human colorectal cancers [J].
Ilyas, M ;
Tomlinson, IPM ;
Rowan, A ;
Pignatelli, M ;
Bodmer, WF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (19) :10330-10334
[8]
JINNAI D, 1983, JPN J SURG, V13, P557
[9]
KIKUCHIYANOSHITA R, 1992, CANCER RES, V52, P3965
[10]
Lessons from hereditary colorectal cancer [J].
Kinzler, KW ;
Vogelstein, B .
CELL, 1996, 87 (02) :159-170